Clinical Trial Update: Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of Endostatin with Docetaxel for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Endostatin (endostatin)

Snippet

Sponsor: Fudan University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN